Huge day for patients with MASH. Our paper in Nature Med showing improved outcomes in cirrhotics w bariatric surgery and then akerotx showing reversal of cirrhosis!! So happy. Mazen Noureddin, MD, MHSc Ali Aminian Arizona Liver Health AASLD Foundation ACG nature.com/articles/s4159…

MASH (NAFLD) related Cirrhosis is both major risk factor for developing hepatocellular carcinoma & fastest growing cause of it in USA 🇺🇸& Europe. Results of this study makes a compelling case for studying efruxifermin (EFX) impact on OS inpatients with MASH related #HCC

This article is a hard but important read, highlighting the incredible efforts of individuals doing their best in difficult circumstances. It serves as a reminder that many face struggles we may never fully grasp, and that privilege is often invisible until we step outside our

This study demonstrates that multiparametric MRI is a cost-effective, non-invasive diagnostic tool that can enhance #MASLD detection, reduce dependence on liver biopsies, and improve overall healthcare efficiency. Diagnostic innovations that streamline clinical workflows while

Today, on the one-year anniversary of his passing, we honor the extraordinary life and legacy of Dr. Stephen A. Harrison—a pioneering physician-scientist, compassionate caregiver, and steadfast ally to the patient community. As one of the world’s most cited liver disease

"I refuse to give up." Aroosha has lived with #MASH since 2018—and she’s turned fear into action. In this #SharingJourneys clip, she shares how becoming her own advocate gave her back control, purpose, and joy. Watch her full story & meet others: bit.ly/3W1e0Mb

Today, on Global Fatty Liver Day, Fatty Liver Foundation is proud to announce the launch of the Dr. Stephen A. Harrison Patient Advocacy Fellowship, a first-of-its-kind program dedicated to training and supporting liver disease advocates across the U.S., the U.K., and the EU. WHAT: A

Dr. Annabel Vila recalls missing the signs of MASH, even as a doctor. "It was my own wake-up call to the importance of early detection, self-care, and advocacy." Annabel shares her story to help others catch liver disease early and make lasting lifestyle changes. 🌱 🎧

Too many people at high risk for #MASH go undiagnosed because they don’t show obvious symptoms. Aroosha shares why awareness and early screening matter - especially for those who might not know they’re at risk. Hear her story in #SharingJourneys bit.ly/3W1e0Mb

🚨 Applications now open! 🚨 Do you have lived experience with steatotic liver disease or advocate for those who do? Are you passionate about changing the future of liver health? Apply now for the Dr. Stephen A. Harrison Patient Advocacy Fellowship, a programme supporting and

Deeply grateful to EASLnews for championing this important effort. The Dr. Stephen A. Harrison Patient Advocacy Fellowship aims to build and equip the next-generation of patient advocates to ensure a truly patient-centric approach in the development of drugs and diagnostics for

You don’t have to tell the whole story to make an impact. All 49 questions in this survey are optional. You decide what to share: shorturl.at/Ai2M4

📣#MetALD: An Emerging Diagnosis Changing #ALD Care Pre- & Post-#Transplant. Featuring, leading expert, Dr. Juan Pablo Arab, 07/24, 8pm ET on Zoom. Send to patients! Receive an invite-join our no-cost community! bit.ly/4o1XmJq #LiverTwitter #Cirrhosis #AUD #LiverHealth

We’ve expanded The Wellness League’s Search Tool to include national resources that address the most pressing SDOH challenges reported by our patient community. From transportation to mental health to prescription savings, this tool is designed to remove barriers to care.

Liver care conversations often center labs, imaging, and medications. This survey centers you. What’s it like to live with steatotic (fatty) liver disease? What’s missing in care? What matters most? Tell us: shorturl.at/Ai2M4